Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
The findings by researchers from Sansum Diabetes Research Institute (SDRI) and Rice University are available online this week in EClinicalMedicine, an open-access clinical journal published by The Lancet.
"The fresh look at the glucose data sheds new light on disease progression, which could have a direct impact on better management," said Rice study co-author Ashutosh Sabharwal, professor and department chair in electrical and computer engineering and founder of Rice's Scalable Health Labs. "An important aspect of our analysis is that the results are clinically interpretable and point to new directions for improved Type 2 diabetes care."
I think that there are a lot of Type 2s who would benefit from CGM/Libre technology, as an advancement of the 'Test/Review/Adjust' strategy for getting their levels under control - particularly those newly-diagnosed or struggling 🙂
The findings by researchers from Sansum Diabetes Research Institute (SDRI) and Rice University are available online this week in EClinicalMedicine, an open-access clinical journal published by The Lancet.
"The fresh look at the glucose data sheds new light on disease progression, which could have a direct impact on better management," said Rice study co-author Ashutosh Sabharwal, professor and department chair in electrical and computer engineering and founder of Rice's Scalable Health Labs. "An important aspect of our analysis is that the results are clinically interpretable and point to new directions for improved Type 2 diabetes care."
Wearable glucose monitors shed light on progression of Type 2 diabetes in Hispanic adults
Researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
www.sciencedaily.com
I think that there are a lot of Type 2s who would benefit from CGM/Libre technology, as an advancement of the 'Test/Review/Adjust' strategy for getting their levels under control - particularly those newly-diagnosed or struggling 🙂
